Home
>
National Drug Code (NDC)
>
Nateglinide
Nateglinide - 0591-3355-10 - (Nateglinide)
Drug Information of Nateglinide
| Product NDC: | 0591-3355 |
| Proprietary Name: | Nateglinide |
| Non Proprietary Name: | Nateglinide |
| Active Ingredient(s): | 120 mg/1 & nbsp; Nateglinide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nateglinide
| Product NDC: | 0591-3355 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077462 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110330 |
Package Information of Nateglinide
| Package NDC: | 0591-3355-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE, PLASTIC (0591-3355-10) |
NDC Information of Nateglinide
| NDC Code | 0591-3355-10 |
| Proprietary Name | Nateglinide |
| Package Description | 1000 TABLET in 1 BOTTLE, PLASTIC (0591-3355-10) |
| Product NDC | 0591-3355 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nateglinide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110330 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | NATEGLINIDE |
| Strength Number | 120 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Glinide [EPC],Potassium Channel Antagonists [MoA] |
